Atea Pharmaceuticals
NASDAQ: AVIRBoston, US · Founded 2012 · Massachusetts corporation · 2 known investors
Atea is a clinical-stage biopharmaceutical company developing oral direct-acting antiviral therapies for single-stranded RNA viruses, currently focused on a bemnifosbuvir and ruzasvir regimen in Phase 3 development for hepatitis C virus (HCV). Its work spans antiviral drug discovery, medicinal chemistry, biology, and virology.
BiotechHealthtech
Founders & leadership
Atea Pharmaceuticals was founded in 2012 by Jean-Pierre Sommadossi, Ph.D..
JS
Jean-Pierre Sommadossi, Ph.D.Founder
Board
BL
Bruno LucidiBoard director
EZ
Evgeny ZatsevBoard director
FY
Frank YuBoard director
GC
Gerald ChanBoard director
BP
Bruce PolskyBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$175.9M disclosed across 4 rounds · 2013–2020
▶$107.5MraisedMay 2020 · 37 investors · BiotechnologyRule 506(b)
▶$107.5MraisedMay 2020 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Pierre Sommadossi, Ph.D.Executive Officer, Director
- Andrew Hack, M.D., Ph.D.Director
- Bruno LucidiDirector
- Bruce PolskyDirector
- Andrea CorcoranExecutive Officer
- Bihua ChenDirector
- Franklin BergerDirector
- Grigory BorisenkoDirector
- Isaac Cheng, M.D.Director
- Offering amount
- $215M
- Amount sold
- $107.5M
- Sales commissions
- $500K
- Placement agents
- William Blair
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.6MraisedJul 2018 · 38 investors · BiotechnologyRule 506(b)
▶$27.6MraisedJul 2018 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald ChanDirector
- Evgeny ZatsevDirector
- Jean-Pierre SommadossiExecutive Officer, Director
- Bruce PolskyDirector
- Fan YuDirector
- Andrea CorcoranExecutive Officer
- Bihua ChenDirector
- Bruno LucidiDirector
- Offering amount
- $27.6M
- Amount sold
- $27.6M
- Sales commissions
- $119.5K
- Placement agents
- CIM Securities, LLC
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.8MraisedSep 2016 · 29 investors · BiotechnologyRule 506(b)
▶$20.8MraisedSep 2016 · 29 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruno LucidiDirector
- Jean-Pierre Sommadossi, Ph.D.Executive Officer, Director
- Evgeny ZatsevDirector
- Frank YuDirector
- Gerald ChanDirector
- Bruce PolskyDirector
- Offering amount
- $20.8M
- Amount sold
- $20.8M
- Sales commissions
- $167K
- Placement agents
- CIM Securities
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$20MraisedSep 2014 · 59 investors · OtherRule 506(b)
▶$20MraisedSep 2014 · 59 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jean-Pierre Sommadossi, Ph.D.Executive Officer, Director
- Offering amount
- $20M
- Amount sold
- $20M
- Minimum investment
- $25K
- Sales commissions
- $811.1K
- Placement agents
- Brookline Group, LLC
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Atea Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Atea Pharmaceuticals do?
- Atea is a clinical-stage biopharmaceutical company developing oral direct-acting antiviral therapies for single-stranded RNA viruses, currently focused on a bemnifosbuvir and ruzasvir regimen in Phase 3 development for hepatitis C virus (HCV). Its work spans antiviral drug discovery, medicinal chemistry, biology, and virology.
- Who founded Atea Pharmaceuticals?
- Atea Pharmaceuticals was founded by Jean-Pierre Sommadossi, Ph.D. in 2012.
- Who are Atea Pharmaceuticals's investors?
- Atea Pharmaceuticals's investors include Bain Capital Life Sciences, RA Capital.
- How much funding has Atea Pharmaceuticals raised?
- Atea Pharmaceuticals has disclosed $175.9M raised across 4 rounds.
- Where is Atea Pharmaceuticals headquartered?
- Atea Pharmaceuticals is headquartered in Boston, US.